Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-08

Clinical Trial Update: VA-005 Clinical Outcomes of VIGIV Treatment of Smallpox Vaccination Complications or Vaccinia Infection

View source ↗

Summary

The document provides an update on the VA-005 trial evaluating vaccinia immune globulin intravenous (VIGIV) for treating complications of smallpox vaccination o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VIGIV (Vaccinia immune globulin intravenous)

Snippet

Sponsor: Emergent BioSolutions | Conditions: Complication of Smallpox Vaccination | Status: ENROLLING_BY_INVITATION